2014

1. The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-Mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial

   Clinical Cancer Research, Vol. 20, Núm. 7, pp. 2001-2010